Zinc inhibits nuclear factor-κB activation and sensitizes prostate cancer cells to cytotoxic agents

Clinical Cancer Research

Volumn 8, Issue 11, 2002, Pages 3579-3583

  Uzzo, Robert G ^a   Leavis, Paul ^b   Hatch, William ^b   Gabai, Vladimir L ^c   Dulin, Nickolai ^e   Zvartau, Nadezhda ^f   Kolenko, Vladimir M ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^e UNIVERSITY OF CHICAGO   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PACLITAXEL; PYRITHIONE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; ZINC; ZINC SULFATE; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CASPASE; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE CHLOROMETHYL KETONE; PROTEIN;

ARTICLE; CARCINOGENESIS; CELL DEATH; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NICK END LABELING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; ACTIVE TRANSPORT; APOPTOSIS; CELL CULTURE; DRUG ANTAGONISM; FLOW CYTOMETRY; MALE; METABOLISM; PROSTATE TUMOR; TIME; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; BLOTTING, WESTERN; CASPASES; ENZYME INHIBITORS; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PACLITAXEL; PROSTATIC NEOPLASMS; PROTEINS; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; ZINC;

EID: 0036847701     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Gilmore, T. D. The Rel/NF-κB signal transduction pathway: Introduction. Oncogene. 18: 6842-6844, 1999
2. Hsu, T. C., Nair, R., Tulsian, P., Camalier, C. E., Hegamyer, G. A., Young, M. R., and Colburn, N. H. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-κB activation. Cancer Res., 61: 4160-4168, 2001
3. Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., Jr., and Sledge, G. W., Jr. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol., 17: 3629-3639, 1997
4. Kimura, K., Markowski, M., Bowen, C., and Gelmann, E. P. Androgen blocks apoptosis of hormone-dependent prostate cancer cells. Cancer Res., 61: 5611-5618, 2001
5. Wang, C. Y., Cusack, J. C., Jr., Liu, R., and Baldwin, A. S., Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nat. Med., 5: 412-417, 1999
6. Tu, Y., Renner, S., Xu, F., Fleishman, A., Taylor, J., Weisz, J., Vescio, R., Rettig, M., Berenson, J., Krajewski, S., Reed, J. C., and Lichtenstein, A. BCL-X expression in multiple myeloma: Possible indicator of chemoresistance. Cancer Res., 58: 256-262, 1998
7. Muenchen, H. J., Lin, D. L., Walsh, M. A., Keller, E. T., and Pienta, K. J. Tumor necrosis factor-α-induced apoptosis in prostate cancer cells through inhibition of nuclear factor-κB by an IκBα "super-repressor." Clin Cancer Res., 6: 1969-1977, 2000
8. Huang, S., Pettaway, C. A., Uehara, H., Bucana, C. D., and Fidler, I. J. Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene, 20: 4188-4197, 2001
9. Ogunlewe, J. O., and Osegbe, D. N. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate. Cancer (Phila.), 63: 1388-1392, 1989
10. Zaichick, V., Sviridova, T. V., and Zaichick, S. V. Zinc in the human prostate gland: Normal, hyperplastic and cancerous. Int. Urol. Nephrol., 29: 565-574, 1997
11. Costello, L. C., and Franklin, R. B. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate, 35: 285-296, 1998
12. Costello, L. C., and Franklin, R. B. The intermediary metabolism of the prostate: A key to understanding the pathogenesis and progression of prostate malignancy. Oncology, 59: 269-282, 2000
13. Liang, J. Y., Liu, Y. Y., Zou, J., Franklin, R. B., Costello, L. C., and Feng, P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate, 40: 200-207, 1999
14. Kolenko, V., Bloom, T., Rayman, P., Bukowski, R., Hsi, E., and Finke, J. Inhibition of NF-κB activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. J. Immunol., 163: 590-598, 1999
15. Palayoor, S. T., Youmell, M. Y., Calderwood, S. K., Coleman, C. N., and Price, B. D. Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen. Oncogene, 18: 7389-7394, 1999
16. Supakar, P. C., Jung, M. H., Song, C. S., Chatterjee, B., and Roy, A. K. Nuclear factor κB functions as a negative regulator for the rat androgen receptor gene and NF-κB activity increases during the age-dependent desensitization of the liver. J. Biol. Chem., 270: 837-842, 1995
17. Mizokami, A., Gotoh, A., Yamada, H., Keller, E. T., and Matsumoto, T. Tumor necrosis factor-α represses androgen sensitivity in the LNCaP prostate cancer cell line. J. Urol., 164: 800-805, 2000
18. Nakajima, Y., DelliPizzi, A., Mallouh, C., and Ferreri, N. R. Effect of tumor necrosis factor-α and interferon-γ on the growth of human prostate cancer cell lines. Urol. Res., 23: 205-210, 1995
19. Bloem, A., and Lockhorst, H. Bcl-2 antisense therapy in multiple myeloma. Pathol. Biol. (Paris), 47: 216-220, 1999
20. McConkey, D. J., Chandra, J., Wright, S., Plunkett, W., McDonnell, T. J., Reed, J. C., and Keating, M. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. J. Immunol., 156: 2624-2630, 1996
21. Connell, P., Young, V. M., Toborek, M., Cohen, D. A., Barve, S., McClain, C. J., and Hennig, B. Zinc attenuates tumor necrosis factormediated activation of transcription factors in endothelial cells. J. Am. Coll. Nutr., 16: 411-417, 1997
22. Kim, C. H., Kim, J. H., Hsu, C. Y., and Ahn, Y. S. Zinc is required in pyrrolidine dithiocarbamate inhibition of NF-κB activation. FEBS Lett., 449: 28-32, 1999
23. Kim, C. H., Kim, J. H., Moon, S. J., Chung, K. C., Hsu, C. Y., Seo, J. T., and Ahn, Y. S. Pyrithione, a zinc ionophore, inhibits NF-κB activation. Biochem. Biophys. Res. Commun., 259: 505-509, 1999
24. Shumilla, J. A., Wetterhahn, K. E., and Barchowsky, A. Inhibition of NF-κB binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: Evidence of a thiol mechanism. Arch. Biochem. Biophys., 349: 356-362, 1998
25. L. Mol. Cell. Biol., 20: 2687-2695, 2000
26. Chu, Z. L., McKinsey, T. A., Liu, L., Gentry, J. J., Malim. M. H., and Ballard, D. W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. USA. 94: 10057-10062, 1997
27. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., and Baldwin, A. S., Jr. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science (Wash. DC), 281: 1680-1683, 1998
28. Javelaud, D., and Besancon, F. NF-κB activation results in rapid inactivation of JNK in TNF α-treated Ewing sarcoma cells: A mechanism for the anti-apoptotic effect of NF-κB. Oncogene, 20: 4365-4372, 2001
29. Jeon, K. I., Jeong, J. Y., and Jue, D. M. Thiol-reactive metal compounds inhibit NF-κB activation by blocking IκB kinase. J. Immunol., 164: 5981-5989, 2000
30. Costello, L. C., Liu, Y., Zou, J., and Franklin, R. B. Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J. Biol. Chem., 274: 17499-17504, 1999
31. McMahon, R. J., and Cousins, R. J. Mammalian zinc transporters. J. Nutr., 128: 667-670, 1998
32. Gaither, L. A., and Eide, D. J. Functional expression of the human hZIP2 zinc transporter. J. Biol. Chem., 275: 5560-5564, 2000
33. Gaither, L. A., and Eide, D. J. The human ZIP1 transporter mediates zinc uptake in human K562 erythroleukemia cells. J. Biol. Chem., 276: 22258-22264, 2001
34. Grotz, N., Fox, T., Connolly, E., Park, W., Guerinot, M. L., and Eide, D. Identification of a family of zinc transporter genes from Arabidopsis that respond to zinc deficiency. Proc. Natl. Acad. Sci. USA, 95: 7220-7224, 1998